nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—hypertension	0.0716	0.522	CbGaD
Bortezomib—CYP1A1—hypertension	0.0655	0.478	CbGaD
Bortezomib—Aspartame—Quinapril—hypertension	0.0415	0.143	CrCrCtD
Bortezomib—Nateglinide—Trandolapril—hypertension	0.036	0.124	CrCrCtD
Bortezomib—Nateglinide—Enalapril—hypertension	0.036	0.124	CrCrCtD
Bortezomib—Aspartame—Enalapril—hypertension	0.0342	0.118	CrCrCtD
Bortezomib—Aspartame—Trandolapril—hypertension	0.0342	0.118	CrCrCtD
Bortezomib—Nateglinide—Lisinopril—hypertension	0.0282	0.0971	CrCrCtD
Bortezomib—Nateglinide—Ramipril—hypertension	0.0273	0.0941	CrCrCtD
Bortezomib—Aspartame—Lisinopril—hypertension	0.0268	0.0923	CrCrCtD
Bortezomib—Aspartame—Ramipril—hypertension	0.0259	0.0893	CrCrCtD
Bortezomib—PTGS1—Minoxidil—hypertension	0.0108	0.036	CbGbCtD
Bortezomib—PTGS1—Torasemide—hypertension	0.0099	0.033	CbGbCtD
Bortezomib—PTGS1—Candesartan—hypertension	0.0092	0.0306	CbGbCtD
Bortezomib—CYP1A1—Prazosin—hypertension	0.00593	0.0197	CbGbCtD
Bortezomib—CYP2C8—Torasemide—hypertension	0.00571	0.019	CbGbCtD
Bortezomib—PTGS1—Irbesartan—hypertension	0.00569	0.0189	CbGbCtD
Bortezomib—CYP1A1—Amlodipine—hypertension	0.00558	0.0186	CbGbCtD
Bortezomib—CYP2C8—Candesartan—hypertension	0.00531	0.0177	CbGbCtD
Bortezomib—CYP1A1—Nifedipine—hypertension	0.0052	0.0173	CbGbCtD
Bortezomib—CYP1A1—Carvedilol—hypertension	0.00512	0.017	CbGbCtD
Bortezomib—PTGS1—Carvedilol—hypertension	0.00512	0.017	CbGbCtD
Bortezomib—CYP2C9—Eprosartan—hypertension	0.00489	0.0163	CbGbCtD
Bortezomib—CYP2C19—Torasemide—hypertension	0.00479	0.016	CbGbCtD
Bortezomib—CYP1A1—Propranolol—hypertension	0.00471	0.0157	CbGbCtD
Bortezomib—CYP1A1—Clonidine—hypertension	0.00449	0.015	CbGbCtD
Bortezomib—CYP2C19—Metoprolol—hypertension	0.00446	0.0148	CbGbCtD
Bortezomib—CYP2C19—Guanfacine—hypertension	0.00446	0.0148	CbGbCtD
Bortezomib—CYP1A2—Triamterene—hypertension	0.00442	0.0147	CbGbCtD
Bortezomib—CYP1A2—Guanabenz—hypertension	0.00442	0.0147	CbGbCtD
Bortezomib—CYP2C8—Diltiazem—hypertension	0.00403	0.0134	CbGbCtD
Bortezomib—CYP2C9—Torasemide—hypertension	0.00398	0.0133	CbGbCtD
Bortezomib—CYP2D6—Labetalol—hypertension	0.00398	0.0133	CbGbCtD
Bortezomib—CYP2D6—Nebivolol—hypertension	0.00398	0.0133	CbGbCtD
Bortezomib—CYP2C9—Candesartan—hypertension	0.0037	0.0123	CbGbCtD
Bortezomib—CYP2C9—Guanfacine—hypertension	0.0037	0.0123	CbGbCtD
Bortezomib—CYP1A2—Betaxolol—hypertension	0.00366	0.0122	CbGbCtD
Bortezomib—CYP2D6—Acebutolol—hypertension	0.00364	0.0121	CbGbCtD
Bortezomib—CYP2C19—Doxazosin—hypertension	0.0035	0.0116	CbGbCtD
Bortezomib—CYP2D6—Metoprolol—hypertension	0.00339	0.0113	CbGbCtD
Bortezomib—CYP2D6—Pindolol—hypertension	0.00339	0.0113	CbGbCtD
Bortezomib—CYP2C19—Diltiazem—hypertension	0.00338	0.0112	CbGbCtD
Bortezomib—CYP3A4—Guanethidine—hypertension	0.00334	0.0111	CbGbCtD
Bortezomib—CYP2C8—Irbesartan—hypertension	0.00328	0.0109	CbGbCtD
Bortezomib—CYP1A2—Nisoldipine—hypertension	0.00323	0.0107	CbGbCtD
Bortezomib—CYP2C8—Amlodipine—hypertension	0.00322	0.0107	CbGbCtD
Bortezomib—CYP2C19—Telmisartan—hypertension	0.00318	0.0106	CbGbCtD
Bortezomib—CYP2C8—Spironolactone—hypertension	0.00316	0.0105	CbGbCtD
Bortezomib—CYP2C8—Felodipine—hypertension	0.0031	0.0103	CbGbCtD
Bortezomib—CYP2D6—Betaxolol—hypertension	0.00302	0.0101	CbGbCtD
Bortezomib—CYP2C8—Nifedipine—hypertension	0.003	0.00999	CbGbCtD
Bortezomib—CYP2C8—Nicardipine—hypertension	0.00295	0.00983	CbGbCtD
Bortezomib—CYP2C9—Diltiazem—hypertension	0.00281	0.00935	CbGbCtD
Bortezomib—CYP2D6—Doxazosin—hypertension	0.00266	0.00885	CbGbCtD
Bortezomib—CYP2C9—Valsartan—hypertension	0.00257	0.00855	CbGbCtD
Bortezomib—CYP2D6—Diltiazem—hypertension	0.00257	0.00855	CbGbCtD
Bortezomib—CYP2C19—Timolol—hypertension	0.00256	0.00852	CbGbCtD
Bortezomib—CYP1A2—Irbesartan—hypertension	0.00254	0.00845	CbGbCtD
Bortezomib—CYP3A4—Hydralazine—hypertension	0.00253	0.00843	CbGbCtD
Bortezomib—CYP1A2—Amlodipine—hypertension	0.00249	0.00829	CbGbCtD
Bortezomib—CYP2C19—Nicardipine—hypertension	0.00248	0.00825	CbGbCtD
Bortezomib—CYP1A2—Nifedipine—hypertension	0.00232	0.00773	CbGbCtD
Bortezomib—CYP2C8—Atorvastatin—hypertension	0.00231	0.0077	CbGbCtD
Bortezomib—CYP2C9—Irbesartan—hypertension	0.00229	0.00762	CbGbCtD
Bortezomib—CYP2D6—Bepridil—hypertension	0.00229	0.00762	CbGbCtD
Bortezomib—CYP1A2—Carvedilol—hypertension	0.00229	0.00761	CbGbCtD
Bortezomib—CYP2C19—Propranolol—hypertension	0.00228	0.00759	CbGbCtD
Bortezomib—CYP2C9—Amlodipine—hypertension	0.00224	0.00747	CbGbCtD
Bortezomib—CYP2C9—Felodipine—hypertension	0.00216	0.0072	CbGbCtD
Bortezomib—CYP3A4—Guanfacine—hypertension	0.00215	0.00717	CbGbCtD
Bortezomib—CYP2C8—Losartan—hypertension	0.00211	0.00704	CbGbCtD
Bortezomib—CYP1A2—Propranolol—hypertension	0.0021	0.00701	CbGbCtD
Bortezomib—CYP2C9—Nifedipine—hypertension	0.00209	0.00697	CbGbCtD
Bortezomib—CYP2D6—Irbesartan—hypertension	0.00209	0.00697	CbGbCtD
Bortezomib—CYP2C9—Nicardipine—hypertension	0.00206	0.00686	CbGbCtD
Bortezomib—CYP2C9—Carvedilol—hypertension	0.00206	0.00686	CbGbCtD
Bortezomib—CYP2D6—Amlodipine—hypertension	0.00205	0.00683	CbGbCtD
Bortezomib—CYP1A2—Clonidine—hypertension	0.00201	0.00668	CbGbCtD
Bortezomib—CYP2D6—Felodipine—hypertension	0.00198	0.00659	CbGbCtD
Bortezomib—CYP2D6—Timolol—hypertension	0.00195	0.00648	CbGbCtD
Bortezomib—CYP2C19—Atorvastatin—hypertension	0.00194	0.00646	CbGbCtD
Bortezomib—CYP3A4—Isradipine—hypertension	0.00192	0.00639	CbGbCtD
Bortezomib—CYP2D6—Nifedipine—hypertension	0.00191	0.00637	CbGbCtD
Bortezomib—CYP2D6—Nicardipine—hypertension	0.00188	0.00627	CbGbCtD
Bortezomib—CYP2D6—Carvedilol—hypertension	0.00188	0.00627	CbGbCtD
Bortezomib—CYP2C8—Verapamil—hypertension	0.00187	0.00621	CbGbCtD
Bortezomib—CYP2C19—Losartan—hypertension	0.00177	0.0059	CbGbCtD
Bortezomib—CYP2D6—Propranolol—hypertension	0.00173	0.00577	CbGbCtD
Bortezomib—CYP2D6—Captopril—hypertension	0.00171	0.0057	CbGbCtD
Bortezomib—CYP3A4—Nisoldipine—hypertension	0.00169	0.00563	CbGbCtD
Bortezomib—CYP3A4—Indapamide—hypertension	0.00169	0.00563	CbGbCtD
Bortezomib—CYP2D6—Clonidine—hypertension	0.00165	0.00551	CbGbCtD
Bortezomib—CYP1A2—Losartan—hypertension	0.00164	0.00545	CbGbCtD
Bortezomib—CYP3A4—Diltiazem—hypertension	0.00163	0.00543	CbGbCtD
Bortezomib—CYP3A4—Eplerenone—hypertension	0.00163	0.00543	CbGbCtD
Bortezomib—CYP2C9—Atorvastatin—hypertension	0.00161	0.00537	CbGbCtD
Bortezomib—CYP2C19—Verapamil—hypertension	0.00157	0.00521	CbGbCtD
Bortezomib—CYP2C9—Losartan—hypertension	0.00147	0.00491	CbGbCtD
Bortezomib—CYP2D6—Atorvastatin—hypertension	0.00147	0.00491	CbGbCtD
Bortezomib—CYP3A4—Enalapril—hypertension	0.00146	0.00484	CbGbCtD
Bortezomib—CYP1A2—Verapamil—hypertension	0.00144	0.00481	CbGbCtD
Bortezomib—CYP3A4—Irbesartan—hypertension	0.00133	0.00443	CbGbCtD
Bortezomib—CYP3A4—Amlodipine—hypertension	0.00131	0.00434	CbGbCtD
Bortezomib—CYP2C9—Verapamil—hypertension	0.0013	0.00433	CbGbCtD
Bortezomib—CYP3A4—Felodipine—hypertension	0.00126	0.00419	CbGbCtD
Bortezomib—CYP3A4—Nifedipine—hypertension	0.00122	0.00405	CbGbCtD
Bortezomib—CYP3A4—Carvedilol—hypertension	0.0012	0.00399	CbGbCtD
Bortezomib—CYP3A4—Nicardipine—hypertension	0.0012	0.00399	CbGbCtD
Bortezomib—CYP2D6—Verapamil—hypertension	0.00119	0.00396	CbGbCtD
Bortezomib—CYP3A4—Propranolol—hypertension	0.0011	0.00367	CbGbCtD
Bortezomib—CYP3A4—Clonidine—hypertension	0.00105	0.0035	CbGbCtD
Bortezomib—CTSG—myocardium—hypertension	0.000953	0.0215	CbGeAlD
Bortezomib—CYP3A4—Atorvastatin—hypertension	0.000938	0.00312	CbGbCtD
Bortezomib—CYP3A4—Losartan—hypertension	0.000858	0.00285	CbGbCtD
Bortezomib—PSMD1—cardiac ventricle—hypertension	0.000816	0.0184	CbGeAlD
Bortezomib—PSMD1—myocardium—hypertension	0.000768	0.0173	CbGeAlD
Bortezomib—CYP3A4—Verapamil—hypertension	0.000757	0.00252	CbGbCtD
Bortezomib—PSMD2—cardiac ventricle—hypertension	0.000723	0.0163	CbGeAlD
Bortezomib—PSMD2—myocardium—hypertension	0.00068	0.0153	CbGeAlD
Bortezomib—CTSG—heart—hypertension	0.000665	0.015	CbGeAlD
Bortezomib—PSMA1—heart—hypertension	0.000638	0.0144	CbGeAlD
Bortezomib—PSMB5—cardiac ventricle—hypertension	0.000635	0.0143	CbGeAlD
Bortezomib—CTSG—cardiovascular system—hypertension	0.000627	0.0141	CbGeAlD
Bortezomib—PSMA1—cardiovascular system—hypertension	0.000602	0.0136	CbGeAlD
Bortezomib—PSMB5—myocardium—hypertension	0.000597	0.0135	CbGeAlD
Bortezomib—CTSG—cardiac atrium—hypertension	0.000569	0.0128	CbGeAlD
Bortezomib—PSMD1—nephron tubule—hypertension	0.000563	0.0127	CbGeAlD
Bortezomib—PSMB1—cardiac ventricle—hypertension	0.000555	0.0125	CbGeAlD
Bortezomib—PSMD1—adrenal cortex—hypertension	0.000554	0.0125	CbGeAlD
Bortezomib—PSMB2—cardiac ventricle—hypertension	0.000541	0.0122	CbGeAlD
Bortezomib—PSMD1—heart—hypertension	0.000536	0.0121	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—hypertension	0.000532	0.012	CbGeAlD
Bortezomib—PSMB1—myocardium—hypertension	0.000522	0.0118	CbGeAlD
Bortezomib—PSMD1—decidua—hypertension	0.000521	0.0117	CbGeAlD
Bortezomib—PSMB2—myocardium—hypertension	0.000509	0.0115	CbGeAlD
Bortezomib—CYP2C19—urine—hypertension	0.000506	0.0114	CbGeAlD
Bortezomib—PSMD2—nephron tubule—hypertension	0.000499	0.0112	CbGeAlD
Bortezomib—CTSG—adrenal gland—hypertension	0.000496	0.0112	CbGeAlD
Bortezomib—PSMD2—adrenal cortex—hypertension	0.000491	0.0111	CbGeAlD
Bortezomib—PSMB8—adrenal cortex—hypertension	0.000488	0.011	CbGeAlD
Bortezomib—PSMD1—cortex of kidney—hypertension	0.000482	0.0109	CbGeAlD
Bortezomib—PSMA1—adrenal gland—hypertension	0.000476	0.0107	CbGeAlD
Bortezomib—PSMD2—heart—hypertension	0.000475	0.0107	CbGeAlD
Bortezomib—PSMB8—heart—hypertension	0.000472	0.0106	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—hypertension	0.000471	0.0106	CbGeAlD
Bortezomib—PSMD2—decidua—hypertension	0.000462	0.0104	CbGeAlD
Bortezomib—PSMB8—decidua—hypertension	0.000459	0.0103	CbGeAlD
Bortezomib—PSMD1—cardiac atrium—hypertension	0.000458	0.0103	CbGeAlD
Bortezomib—PSMD2—cardiovascular system—hypertension	0.000448	0.0101	CbGeAlD
Bortezomib—SLC31A1—myocardium—hypertension	0.000441	0.00994	CbGeAlD
Bortezomib—PSMD2—kidney—hypertension	0.000438	0.00988	CbGeAlD
Bortezomib—PSMB5—nephron tubule—hypertension	0.000438	0.00987	CbGeAlD
Bortezomib—PSMD1—medulla oblongata—hypertension	0.000432	0.00974	CbGeAlD
Bortezomib—PSMB5—adrenal cortex—hypertension	0.000431	0.00971	CbGeAlD
Bortezomib—CTSG—endocrine gland—hypertension	0.00043	0.0097	CbGeAlD
Bortezomib—PSMD2—cortex of kidney—hypertension	0.000427	0.00962	CbGeAlD
Bortezomib—PSMB8—cortex of kidney—hypertension	0.000424	0.00956	CbGeAlD
Bortezomib—PSMB5—heart—hypertension	0.000417	0.00939	CbGeAlD
Bortezomib—CYP1A2—urine—hypertension	0.000414	0.00932	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—hypertension	0.000413	0.00932	CbGeAlD
Bortezomib—PSMA1—endocrine gland—hypertension	0.000413	0.00931	CbGeAlD
Bortezomib—PSMD2—cardiac atrium—hypertension	0.000406	0.00915	CbGeAlD
Bortezomib—PSMB5—decidua—hypertension	0.000405	0.00913	CbGeAlD
Bortezomib—PSMD1—adrenal gland—hypertension	0.0004	0.00901	CbGeAlD
Bortezomib—CYP2C9—urine—hypertension	0.000393	0.00885	CbGeAlD
Bortezomib—PSMD2—medulla oblongata—hypertension	0.000383	0.00862	CbGeAlD
Bortezomib—PSMB1—nephron tubule—hypertension	0.000383	0.00862	CbGeAlD
Bortezomib—PSMB1—adrenal cortex—hypertension	0.000377	0.00849	CbGeAlD
Bortezomib—PSMB5—cortex of kidney—hypertension	0.000375	0.00844	CbGeAlD
Bortezomib—PSMB2—nephron tubule—hypertension	0.000373	0.00841	CbGeAlD
Bortezomib—PSMA1—central nervous system—hypertension	0.000372	0.00839	CbGeAlD
Bortezomib—PSMB2—adrenal cortex—hypertension	0.000367	0.00828	CbGeAlD
Bortezomib—PSMB1—heart—hypertension	0.000364	0.00821	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—hypertension	0.000361	0.00814	CbGeAlD
Bortezomib—PSMB5—cardiac atrium—hypertension	0.000356	0.00803	CbGeAlD
Bortezomib—PSMB2—heart—hypertension	0.000355	0.00801	CbGeAlD
Bortezomib—PSMD2—adrenal gland—hypertension	0.000354	0.00798	CbGeAlD
Bortezomib—PSMB1—decidua—hypertension	0.000354	0.00798	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—hypertension	0.000353	0.00795	CbGeAlD
Bortezomib—PSMB8—adrenal gland—hypertension	0.000352	0.00794	CbGeAlD
Bortezomib—PSMB2—decidua—hypertension	0.000346	0.00779	CbGeAlD
Bortezomib—PSMB1—cardiovascular system—hypertension	0.000344	0.00775	CbGeAlD
Bortezomib—PSMB1—kidney—hypertension	0.000336	0.00758	CbGeAlD
Bortezomib—PSMB5—medulla oblongata—hypertension	0.000336	0.00757	CbGeAlD
Bortezomib—PSMB2—cardiovascular system—hypertension	0.000335	0.00756	CbGeAlD
Bortezomib—PSMB2—kidney—hypertension	0.000328	0.00739	CbGeAlD
Bortezomib—PSMB1—cortex of kidney—hypertension	0.000328	0.00738	CbGeAlD
Bortezomib—SLC31A1—nephron tubule—hypertension	0.000323	0.00729	CbGeAlD
Bortezomib—PSMB2—cortex of kidney—hypertension	0.00032	0.0072	CbGeAlD
Bortezomib—SLC31A1—adrenal cortex—hypertension	0.000318	0.00717	CbGeAlD
Bortezomib—PSMB1—cardiac atrium—hypertension	0.000312	0.00702	CbGeAlD
Bortezomib—PSMB5—adrenal gland—hypertension	0.000311	0.00701	CbGeAlD
Bortezomib—SLC31A1—heart—hypertension	0.000308	0.00694	CbGeAlD
Bortezomib—PSMD2—endocrine gland—hypertension	0.000307	0.00692	CbGeAlD
Bortezomib—PSMB2—cardiac atrium—hypertension	0.000304	0.00685	CbGeAlD
Bortezomib—Nateglinide—KCNJ11—hypertension	0.000303	0.27	CrCbGaD
Bortezomib—CYP3A4—urine—hypertension	0.000299	0.00675	CbGeAlD
Bortezomib—Lacosamide—CA9—hypertension	0.000298	0.265	CrCbGaD
Bortezomib—CYP2D6—urine—hypertension	0.000295	0.00664	CbGeAlD
Bortezomib—PSMB1—medulla oblongata—hypertension	0.000294	0.00662	CbGeAlD
Bortezomib—PSMB2—medulla oblongata—hypertension	0.000287	0.00646	CbGeAlD
Bortezomib—SLC31A1—kidney—hypertension	0.000284	0.0064	CbGeAlD
Bortezomib—PSMD2—central nervous system—hypertension	0.000277	0.00624	CbGeAlD
Bortezomib—SLC31A1—cortex of kidney—hypertension	0.000277	0.00624	CbGeAlD
Bortezomib—PSMB1—adrenal gland—hypertension	0.000272	0.00613	CbGeAlD
Bortezomib—PSMB2—adrenal gland—hypertension	0.000265	0.00598	CbGeAlD
Bortezomib—SLC31A1—cardiac atrium—hypertension	0.000263	0.00593	CbGeAlD
Bortezomib—PTGS1—artery—hypertension	0.000249	0.00562	CbGeAlD
Bortezomib—SLC31A1—medulla oblongata—hypertension	0.000248	0.00559	CbGeAlD
Bortezomib—PSMD2—Hydroflumethiazide—Bendroflumethiazide—hypertension	0.000237	0.103	CbGdCrCtD
Bortezomib—PSMB1—endocrine gland—hypertension	0.000236	0.00531	CbGeAlD
Bortezomib—PSMB2—endocrine gland—hypertension	0.00023	0.00518	CbGeAlD
Bortezomib—SLC31A1—adrenal gland—hypertension	0.00023	0.00518	CbGeAlD
Bortezomib—PSMB1—central nervous system—hypertension	0.000212	0.00479	CbGeAlD
Bortezomib—PTGS1—endothelium—hypertension	0.000211	0.00475	CbGeAlD
Bortezomib—PSMB2—central nervous system—hypertension	0.000207	0.00467	CbGeAlD
Bortezomib—PSMD2—Nitrendipine—Amlodipine—hypertension	0.000206	0.0891	CbGdCrCtD
Bortezomib—PSMD2—Nitrendipine—Isradipine—hypertension	0.000206	0.0891	CbGdCrCtD
Bortezomib—SLC31A1—endocrine gland—hypertension	0.000199	0.00449	CbGeAlD
Bortezomib—PSMD2—Nitrendipine—Nisoldipine—hypertension	0.000197	0.0854	CbGdCrCtD
Bortezomib—PSMD2—Nitrendipine—Felodipine—hypertension	0.000197	0.0854	CbGdCrCtD
Bortezomib—PSMD2—Nitrendipine—Nicardipine—hypertension	0.000197	0.0854	CbGdCrCtD
Bortezomib—PSMD2—Nitrendipine—Nifedipine—hypertension	0.000197	0.0854	CbGdCrCtD
Bortezomib—PTGS1—blood vessel—hypertension	0.000194	0.00438	CbGeAlD
Bortezomib—PSMD2—Hydroflumethiazide—Chlorothiazide—hypertension	0.000186	0.0806	CbGdCrCtD
Bortezomib—SLC31A1—central nervous system—hypertension	0.00018	0.00405	CbGeAlD
Bortezomib—Nateglinide—PPARG—hypertension	0.000168	0.149	CrCbGaD
Bortezomib—Nateglinide—CYP3A5—hypertension	0.000167	0.149	CrCbGaD
Bortezomib—CYP1A1—cardiac ventricle—hypertension	0.000159	0.00359	CbGeAlD
Bortezomib—PSMD2—Hydroflumethiazide—Hydrochlorothiazide—hypertension	0.000147	0.0635	CbGdCrCtD
Bortezomib—PTGS1—myocardium—hypertension	0.000132	0.00296	CbGeAlD
Bortezomib—PSMD2—Hydrochlorothiazide—Bendroflumethiazide—hypertension	0.000131	0.0566	CbGdCrCtD
Bortezomib—Nateglinide—PTGS1—hypertension	0.000124	0.11	CrCbGaD
Bortezomib—PSMD2—Hydrochlorothiazide—Hydroflumethiazide—hypertension	0.000123	0.0532	CbGdCrCtD
Bortezomib—CYP2C8—kidney—hypertension	0.000105	0.00236	CbGeAlD
Bortezomib—CYP1A1—heart—hypertension	0.000105	0.00236	CbGeAlD
Bortezomib—PSMD2—Hydrochlorothiazide—Chlorothiazide—hypertension	0.000102	0.0444	CbGdCrCtD
Bortezomib—CYP2C9—heart—hypertension	0.000101	0.00227	CbGeAlD
Bortezomib—CYP1A1—kidney—hypertension	9.65e-05	0.00217	CbGeAlD
Bortezomib—CYP2C9—cardiovascular system—hypertension	9.49e-05	0.00214	CbGeAlD
Bortezomib—PTGS1—heart—hypertension	9.18e-05	0.00207	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—hypertension	9.11e-05	0.00205	CbGeAlD
Bortezomib—CYP1A1—cardiac atrium—hypertension	8.94e-05	0.00201	CbGeAlD
Bortezomib—CYP2D6—brainstem—hypertension	8.73e-05	0.00197	CbGeAlD
Bortezomib—PTGS1—cardiovascular system—hypertension	8.67e-05	0.00195	CbGeAlD
Bortezomib—PTGS1—kidney—hypertension	8.48e-05	0.00191	CbGeAlD
Bortezomib—CYP2C19—endocrine gland—hypertension	8.4e-05	0.00189	CbGeAlD
Bortezomib—PTGS1—cardiac atrium—hypertension	7.85e-05	0.00177	CbGeAlD
Bortezomib—SLC31A1—Terbinafine—Propranolol—hypertension	7.48e-05	0.0324	CbGdCrCtD
Bortezomib—CYP2C8—endocrine gland—hypertension	7.33e-05	0.00165	CbGeAlD
Bortezomib—CYP3A4—kidney—hypertension	7.08e-05	0.0016	CbGeAlD
Bortezomib—CYP2D6—kidney—hypertension	6.97e-05	0.00157	CbGeAlD
Bortezomib—CYP1A2—endocrine gland—hypertension	6.86e-05	0.00155	CbGeAlD
Bortezomib—PTGS1—adrenal gland—hypertension	6.85e-05	0.00154	CbGeAlD
Bortezomib—CYP1A1—endocrine gland—hypertension	6.77e-05	0.00152	CbGeAlD
Bortezomib—CYP2C9—endocrine gland—hypertension	6.51e-05	0.00147	CbGeAlD
Bortezomib—Nateglinide—ALB—hypertension	6.31e-05	0.0562	CrCbGaD
Bortezomib—PSMB8—Fluvastatin—Atorvastatin—hypertension	6.28e-05	0.0272	CbGdCrCtD
Bortezomib—CYP1A1—central nervous system—hypertension	6.1e-05	0.00137	CbGeAlD
Bortezomib—PTGS1—endocrine gland—hypertension	5.94e-05	0.00134	CbGeAlD
Bortezomib—PTGS1—central nervous system—hypertension	5.36e-05	0.00121	CbGeAlD
Bortezomib—CYP3A4—endocrine gland—hypertension	4.96e-05	0.00112	CbGeAlD
Bortezomib—CYP2D6—endocrine gland—hypertension	4.89e-05	0.0011	CbGeAlD
Bortezomib—CYP3A4—central nervous system—hypertension	4.47e-05	0.00101	CbGeAlD
Bortezomib—CYP2D6—central nervous system—hypertension	4.4e-05	0.000992	CbGeAlD
Bortezomib—PSMB8—Testosterone Propionate—Eplerenone—hypertension	2.45e-05	0.0106	CbGdCrCtD
Bortezomib—PSMB8—Testosterone Propionate—Spironolactone—hypertension	2.13e-05	0.00923	CbGdCrCtD
Bortezomib—Abdominal pain—Irbesartan—hypertension	7.03e-06	5.22e-05	CcSEcCtD
Bortezomib—Body temperature increased—Irbesartan—hypertension	7.03e-06	5.22e-05	CcSEcCtD
Bortezomib—Thrombocytopenia—Ramipril—hypertension	7.02e-06	5.21e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Timolol—hypertension	7.01e-06	5.21e-05	CcSEcCtD
Bortezomib—Oedema—Timolol—hypertension	7.01e-06	5.21e-05	CcSEcCtD
Bortezomib—Loss of consciousness—Lisinopril—hypertension	7.01e-06	5.2e-05	CcSEcCtD
Bortezomib—Rash—Verapamil—hypertension	7e-06	5.2e-05	CcSEcCtD
Bortezomib—Urticaria—Hydrochlorothiazide—hypertension	7e-06	5.2e-05	CcSEcCtD
Bortezomib—Tachycardia—Ramipril—hypertension	7e-06	5.2e-05	CcSEcCtD
Bortezomib—Dermatitis—Verapamil—hypertension	7e-06	5.2e-05	CcSEcCtD
Bortezomib—Headache—Nifedipine—hypertension	6.99e-06	5.19e-05	CcSEcCtD
Bortezomib—Pruritus—Clonidine—hypertension	6.98e-06	5.18e-05	CcSEcCtD
Bortezomib—Body temperature increased—Hydrochlorothiazide—hypertension	6.97e-06	5.17e-05	CcSEcCtD
Bortezomib—Abdominal pain—Hydrochlorothiazide—hypertension	6.97e-06	5.17e-05	CcSEcCtD
Bortezomib—Skin disorder—Ramipril—hypertension	6.97e-06	5.17e-05	CcSEcCtD
Bortezomib—Infection—Timolol—hypertension	6.97e-06	5.17e-05	CcSEcCtD
Bortezomib—Headache—Verapamil—hypertension	6.96e-06	5.17e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Telmisartan—hypertension	6.96e-06	5.17e-05	CcSEcCtD
Bortezomib—Cough—Lisinopril—hypertension	6.96e-06	5.16e-05	CcSEcCtD
Bortezomib—Nausea—Diltiazem—hypertension	6.94e-06	5.16e-05	CcSEcCtD
Bortezomib—Nausea—Indapamide—hypertension	6.94e-06	5.16e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Ramipril—hypertension	6.93e-06	5.15e-05	CcSEcCtD
Bortezomib—Asthenia—Trandolapril—hypertension	6.9e-06	5.12e-05	CcSEcCtD
Bortezomib—Shock—Timolol—hypertension	6.9e-06	5.12e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Losartan—hypertension	6.89e-06	5.12e-05	CcSEcCtD
Bortezomib—Urticaria—Furosemide—hypertension	6.89e-06	5.11e-05	CcSEcCtD
Bortezomib—Nervous system disorder—Timolol—hypertension	6.88e-06	5.11e-05	CcSEcCtD
Bortezomib—Nausea—Carvedilol—hypertension	6.88e-06	5.11e-05	CcSEcCtD
Bortezomib—Asthenia—Enalapril—hypertension	6.87e-06	5.1e-05	CcSEcCtD
Bortezomib—Abdominal pain—Furosemide—hypertension	6.85e-06	5.09e-05	CcSEcCtD
Bortezomib—Body temperature increased—Furosemide—hypertension	6.85e-06	5.09e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Losartan—hypertension	6.84e-06	5.08e-05	CcSEcCtD
Bortezomib—Dizziness—Valsartan—hypertension	6.84e-06	5.08e-05	CcSEcCtD
Bortezomib—Anorexia—Ramipril—hypertension	6.84e-06	5.08e-05	CcSEcCtD
Bortezomib—Urticaria—Betaxolol—hypertension	6.82e-06	5.06e-05	CcSEcCtD
Bortezomib—Skin disorder—Timolol—hypertension	6.81e-06	5.06e-05	CcSEcCtD
Bortezomib—Dizziness—Olmesartan—hypertension	6.81e-06	5.05e-05	CcSEcCtD
Bortezomib—Pruritus—Trandolapril—hypertension	6.8e-06	5.05e-05	CcSEcCtD
Bortezomib—Nausea—Doxazosin—hypertension	6.8e-06	5.05e-05	CcSEcCtD
Bortezomib—Myalgia—Lisinopril—hypertension	6.79e-06	5.04e-05	CcSEcCtD
Bortezomib—Arthralgia—Lisinopril—hypertension	6.79e-06	5.04e-05	CcSEcCtD
Bortezomib—Chest pain—Lisinopril—hypertension	6.79e-06	5.04e-05	CcSEcCtD
Bortezomib—Body temperature increased—Betaxolol—hypertension	6.79e-06	5.04e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Timolol—hypertension	6.78e-06	5.03e-05	CcSEcCtD
Bortezomib—Asthenia—Telmisartan—hypertension	6.78e-06	5.03e-05	CcSEcCtD
Bortezomib—Pruritus—Enalapril—hypertension	6.78e-06	5.03e-05	CcSEcCtD
Bortezomib—Anxiety—Lisinopril—hypertension	6.76e-06	5.02e-05	CcSEcCtD
Bortezomib—Diarrhoea—Clonidine—hypertension	6.75e-06	5.01e-05	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	6.74e-06	5e-05	CcSEcCtD
Bortezomib—Nausea—Fosinopril—hypertension	6.72e-06	4.99e-05	CcSEcCtD
Bortezomib—Discomfort—Lisinopril—hypertension	6.7e-06	4.98e-05	CcSEcCtD
Bortezomib—Hypotension—Ramipril—hypertension	6.7e-06	4.98e-05	CcSEcCtD
Bortezomib—Anorexia—Timolol—hypertension	6.68e-06	4.96e-05	CcSEcCtD
Bortezomib—Pruritus—Telmisartan—hypertension	6.68e-06	4.96e-05	CcSEcCtD
Bortezomib—Nausea—Eplerenone—hypertension	6.68e-06	4.96e-05	CcSEcCtD
Bortezomib—Urticaria—Losartan—hypertension	6.65e-06	4.93e-05	CcSEcCtD
Bortezomib—Nausea—Nifedipine—hypertension	6.63e-06	4.92e-05	CcSEcCtD
Bortezomib—Abdominal pain—Losartan—hypertension	6.61e-06	4.91e-05	CcSEcCtD
Bortezomib—Body temperature increased—Losartan—hypertension	6.61e-06	4.91e-05	CcSEcCtD
Bortezomib—Nausea—Verapamil—hypertension	6.6e-06	4.9e-05	CcSEcCtD
Bortezomib—Asthenia—Captopril—hypertension	6.59e-06	4.89e-05	CcSEcCtD
Bortezomib—Diarrhoea—Trandolapril—hypertension	6.58e-06	4.88e-05	CcSEcCtD
Bortezomib—Vomiting—Valsartan—hypertension	6.58e-06	4.88e-05	CcSEcCtD
Bortezomib—Confusional state—Lisinopril—hypertension	6.56e-06	4.87e-05	CcSEcCtD
Bortezomib—Diarrhoea—Enalapril—hypertension	6.55e-06	4.87e-05	CcSEcCtD
Bortezomib—Hypotension—Timolol—hypertension	6.55e-06	4.86e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Irbesartan—hypertension	6.55e-06	4.86e-05	CcSEcCtD
Bortezomib—Vomiting—Olmesartan—hypertension	6.54e-06	4.86e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Ramipril—hypertension	6.53e-06	4.85e-05	CcSEcCtD
Bortezomib—Rash—Valsartan—hypertension	6.52e-06	4.84e-05	CcSEcCtD
Bortezomib—Dizziness—Clonidine—hypertension	6.52e-06	4.84e-05	CcSEcCtD
Bortezomib—Dermatitis—Valsartan—hypertension	6.52e-06	4.84e-05	CcSEcCtD
Bortezomib—Oedema—Lisinopril—hypertension	6.5e-06	4.83e-05	CcSEcCtD
Bortezomib—Anaphylactic shock—Lisinopril—hypertension	6.5e-06	4.83e-05	CcSEcCtD
Bortezomib—Pruritus—Captopril—hypertension	6.5e-06	4.83e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Hydrochlorothiazide—hypertension	6.5e-06	4.82e-05	CcSEcCtD
Bortezomib—Rash—Olmesartan—hypertension	6.49e-06	4.82e-05	CcSEcCtD
Bortezomib—Insomnia—Ramipril—hypertension	6.49e-06	4.82e-05	CcSEcCtD
Bortezomib—Dermatitis—Olmesartan—hypertension	6.48e-06	4.81e-05	CcSEcCtD
Bortezomib—Headache—Valsartan—hypertension	6.48e-06	4.81e-05	CcSEcCtD
Bortezomib—Diarrhoea—Telmisartan—hypertension	6.46e-06	4.8e-05	CcSEcCtD
Bortezomib—Infection—Lisinopril—hypertension	6.46e-06	4.8e-05	CcSEcCtD
Bortezomib—Headache—Olmesartan—hypertension	6.45e-06	4.79e-05	CcSEcCtD
Bortezomib—Paraesthesia—Ramipril—hypertension	6.44e-06	4.78e-05	CcSEcCtD
Bortezomib—Shock—Lisinopril—hypertension	6.4e-06	4.75e-05	CcSEcCtD
Bortezomib—Asthenia—Perindopril—hypertension	6.4e-06	4.75e-05	CcSEcCtD
Bortezomib—Dyspnoea—Ramipril—hypertension	6.39e-06	4.75e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Timolol—hypertension	6.39e-06	4.74e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Furosemide—hypertension	6.39e-06	4.74e-05	CcSEcCtD
Bortezomib—Asthenia—Irbesartan—hypertension	6.38e-06	4.73e-05	CcSEcCtD
Bortezomib—Thrombocytopenia—Lisinopril—hypertension	6.37e-06	4.73e-05	CcSEcCtD
Bortezomib—Dizziness—Trandolapril—hypertension	6.36e-06	4.72e-05	CcSEcCtD
Bortezomib—Tachycardia—Lisinopril—hypertension	6.35e-06	4.71e-05	CcSEcCtD
Bortezomib—Insomnia—Timolol—hypertension	6.34e-06	4.71e-05	CcSEcCtD
Bortezomib—Dizziness—Enalapril—hypertension	6.33e-06	4.7e-05	CcSEcCtD
Bortezomib—Asthenia—Hydrochlorothiazide—hypertension	6.33e-06	4.7e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Betaxolol—hypertension	6.32e-06	4.7e-05	CcSEcCtD
Bortezomib—Skin disorder—Lisinopril—hypertension	6.32e-06	4.69e-05	CcSEcCtD
Bortezomib—Dyspepsia—Ramipril—hypertension	6.31e-06	4.69e-05	CcSEcCtD
Bortezomib—Pruritus—Perindopril—hypertension	6.31e-06	4.68e-05	CcSEcCtD
Bortezomib—Paraesthesia—Timolol—hypertension	6.3e-06	4.67e-05	CcSEcCtD
Bortezomib—Pruritus—Irbesartan—hypertension	6.29e-06	4.67e-05	CcSEcCtD
Bortezomib—Hyperhidrosis—Lisinopril—hypertension	6.29e-06	4.67e-05	CcSEcCtD
Bortezomib—Diarrhoea—Captopril—hypertension	6.28e-06	4.67e-05	CcSEcCtD
Bortezomib—Vomiting—Clonidine—hypertension	6.27e-06	4.65e-05	CcSEcCtD
Bortezomib—Dyspnoea—Timolol—hypertension	6.25e-06	4.64e-05	CcSEcCtD
Bortezomib—Dizziness—Telmisartan—hypertension	6.25e-06	4.64e-05	CcSEcCtD
Bortezomib—Pruritus—Hydrochlorothiazide—hypertension	6.24e-06	4.63e-05	CcSEcCtD
Bortezomib—Decreased appetite—Ramipril—hypertension	6.24e-06	4.63e-05	CcSEcCtD
Bortezomib—Asthenia—Furosemide—hypertension	6.22e-06	4.62e-05	CcSEcCtD
Bortezomib—Rash—Clonidine—hypertension	6.22e-06	4.62e-05	CcSEcCtD
Bortezomib—Dermatitis—Clonidine—hypertension	6.21e-06	4.61e-05	CcSEcCtD
Bortezomib—Anorexia—Lisinopril—hypertension	6.2e-06	4.6e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Ramipril—hypertension	6.19e-06	4.6e-05	CcSEcCtD
Bortezomib—Fatigue—Ramipril—hypertension	6.18e-06	4.59e-05	CcSEcCtD
Bortezomib—Headache—Clonidine—hypertension	6.18e-06	4.59e-05	CcSEcCtD
Bortezomib—Dyspepsia—Timolol—hypertension	6.17e-06	4.58e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Losartan—hypertension	6.16e-06	4.58e-05	CcSEcCtD
Bortezomib—Asthenia—Betaxolol—hypertension	6.16e-06	4.57e-05	CcSEcCtD
Bortezomib—Nausea—Valsartan—hypertension	6.14e-06	4.56e-05	CcSEcCtD
Bortezomib—Pruritus—Furosemide—hypertension	6.13e-06	4.55e-05	CcSEcCtD
Bortezomib—Constipation—Ramipril—hypertension	6.13e-06	4.55e-05	CcSEcCtD
Bortezomib—Nausea—Olmesartan—hypertension	6.11e-06	4.54e-05	CcSEcCtD
Bortezomib—Vomiting—Trandolapril—hypertension	6.11e-06	4.54e-05	CcSEcCtD
Bortezomib—Diarrhoea—Perindopril—hypertension	6.1e-06	4.53e-05	CcSEcCtD
Bortezomib—Decreased appetite—Timolol—hypertension	6.1e-06	4.53e-05	CcSEcCtD
Bortezomib—Vomiting—Enalapril—hypertension	6.09e-06	4.52e-05	CcSEcCtD
Bortezomib—Diarrhoea—Irbesartan—hypertension	6.08e-06	4.52e-05	CcSEcCtD
Bortezomib—Hypotension—Lisinopril—hypertension	6.08e-06	4.51e-05	CcSEcCtD
Bortezomib—Dizziness—Captopril—hypertension	6.07e-06	4.51e-05	CcSEcCtD
Bortezomib—Pruritus—Betaxolol—hypertension	6.07e-06	4.51e-05	CcSEcCtD
Bortezomib—Rash—Trandolapril—hypertension	6.06e-06	4.5e-05	CcSEcCtD
Bortezomib—Dermatitis—Trandolapril—hypertension	6.06e-06	4.5e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Timolol—hypertension	6.05e-06	4.49e-05	CcSEcCtD
Bortezomib—Fatigue—Timolol—hypertension	6.05e-06	4.49e-05	CcSEcCtD
Bortezomib—Rash—Enalapril—hypertension	6.04e-06	4.48e-05	CcSEcCtD
Bortezomib—Dermatitis—Enalapril—hypertension	6.03e-06	4.48e-05	CcSEcCtD
Bortezomib—Diarrhoea—Hydrochlorothiazide—hypertension	6.03e-06	4.48e-05	CcSEcCtD
Bortezomib—Headache—Trandolapril—hypertension	6.02e-06	4.47e-05	CcSEcCtD
Bortezomib—Vomiting—Telmisartan—hypertension	6.01e-06	4.46e-05	CcSEcCtD
Bortezomib—Asthenia—Losartan—hypertension	6e-06	4.46e-05	CcSEcCtD
Bortezomib—Headache—Enalapril—hypertension	6e-06	4.45e-05	CcSEcCtD
Bortezomib—Pain—Timolol—hypertension	6e-06	4.45e-05	CcSEcCtD
Bortezomib—Rash—Telmisartan—hypertension	5.96e-06	4.42e-05	CcSEcCtD
Bortezomib—Dermatitis—Telmisartan—hypertension	5.95e-06	4.42e-05	CcSEcCtD
Bortezomib—Diarrhoea—Furosemide—hypertension	5.93e-06	4.4e-05	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Lisinopril—hypertension	5.93e-06	4.4e-05	CcSEcCtD
Bortezomib—Pruritus—Losartan—hypertension	5.92e-06	4.39e-05	CcSEcCtD
Bortezomib—Headache—Telmisartan—hypertension	5.92e-06	4.39e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Ramipril—hypertension	5.91e-06	4.39e-05	CcSEcCtD
Bortezomib—Dizziness—Perindopril—hypertension	5.9e-06	4.38e-05	CcSEcCtD
Bortezomib—Insomnia—Lisinopril—hypertension	5.88e-06	4.37e-05	CcSEcCtD
Bortezomib—Dizziness—Irbesartan—hypertension	5.88e-06	4.36e-05	CcSEcCtD
Bortezomib—Diarrhoea—Betaxolol—hypertension	5.87e-06	4.36e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Ramipril—hypertension	5.87e-06	4.35e-05	CcSEcCtD
Bortezomib—Nausea—Clonidine—hypertension	5.86e-06	4.35e-05	CcSEcCtD
Bortezomib—Paraesthesia—Lisinopril—hypertension	5.84e-06	4.34e-05	CcSEcCtD
Bortezomib—Vomiting—Captopril—hypertension	5.84e-06	4.34e-05	CcSEcCtD
Bortezomib—Dizziness—Hydrochlorothiazide—hypertension	5.83e-06	4.33e-05	CcSEcCtD
Bortezomib—Dyspnoea—Lisinopril—hypertension	5.8e-06	4.31e-05	CcSEcCtD
Bortezomib—Rash—Captopril—hypertension	5.79e-06	4.3e-05	CcSEcCtD
Bortezomib—Dermatitis—Captopril—hypertension	5.79e-06	4.3e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Timolol—hypertension	5.78e-06	4.29e-05	CcSEcCtD
Bortezomib—Headache—Captopril—hypertension	5.75e-06	4.27e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Timolol—hypertension	5.73e-06	4.26e-05	CcSEcCtD
Bortezomib—Dizziness—Furosemide—hypertension	5.73e-06	4.26e-05	CcSEcCtD
Bortezomib—Dyspepsia—Lisinopril—hypertension	5.73e-06	4.25e-05	CcSEcCtD
Bortezomib—Diarrhoea—Losartan—hypertension	5.72e-06	4.25e-05	CcSEcCtD
Bortezomib—Nausea—Trandolapril—hypertension	5.71e-06	4.24e-05	CcSEcCtD
Bortezomib—Urticaria—Ramipril—hypertension	5.7e-06	4.23e-05	CcSEcCtD
Bortezomib—Nausea—Enalapril—hypertension	5.69e-06	4.22e-05	CcSEcCtD
Bortezomib—Dizziness—Betaxolol—hypertension	5.68e-06	4.21e-05	CcSEcCtD
Bortezomib—Vomiting—Perindopril—hypertension	5.67e-06	4.21e-05	CcSEcCtD
Bortezomib—Abdominal pain—Ramipril—hypertension	5.67e-06	4.21e-05	CcSEcCtD
Bortezomib—Body temperature increased—Ramipril—hypertension	5.67e-06	4.21e-05	CcSEcCtD
Bortezomib—Decreased appetite—Lisinopril—hypertension	5.65e-06	4.2e-05	CcSEcCtD
Bortezomib—Vomiting—Irbesartan—hypertension	5.65e-06	4.2e-05	CcSEcCtD
Bortezomib—Rash—Perindopril—hypertension	5.62e-06	4.17e-05	CcSEcCtD
Bortezomib—Dermatitis—Perindopril—hypertension	5.62e-06	4.17e-05	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Lisinopril—hypertension	5.62e-06	4.17e-05	CcSEcCtD
Bortezomib—Nausea—Telmisartan—hypertension	5.61e-06	4.17e-05	CcSEcCtD
Bortezomib—Fatigue—Lisinopril—hypertension	5.61e-06	4.16e-05	CcSEcCtD
Bortezomib—Vomiting—Hydrochlorothiazide—hypertension	5.61e-06	4.16e-05	CcSEcCtD
Bortezomib—Rash—Irbesartan—hypertension	5.6e-06	4.16e-05	CcSEcCtD
Bortezomib—Dermatitis—Irbesartan—hypertension	5.6e-06	4.16e-05	CcSEcCtD
Bortezomib—Headache—Perindopril—hypertension	5.59e-06	4.15e-05	CcSEcCtD
Bortezomib—Urticaria—Timolol—hypertension	5.57e-06	4.14e-05	CcSEcCtD
Bortezomib—Headache—Irbesartan—hypertension	5.57e-06	4.13e-05	CcSEcCtD
Bortezomib—Pain—Lisinopril—hypertension	5.56e-06	4.13e-05	CcSEcCtD
Bortezomib—Constipation—Lisinopril—hypertension	5.56e-06	4.13e-05	CcSEcCtD
Bortezomib—Rash—Hydrochlorothiazide—hypertension	5.56e-06	4.13e-05	CcSEcCtD
Bortezomib—Dermatitis—Hydrochlorothiazide—hypertension	5.55e-06	4.12e-05	CcSEcCtD
Bortezomib—Abdominal pain—Timolol—hypertension	5.54e-06	4.12e-05	CcSEcCtD
Bortezomib—Body temperature increased—Timolol—hypertension	5.54e-06	4.12e-05	CcSEcCtD
Bortezomib—Dizziness—Losartan—hypertension	5.53e-06	4.11e-05	CcSEcCtD
Bortezomib—Headache—Hydrochlorothiazide—hypertension	5.52e-06	4.1e-05	CcSEcCtD
Bortezomib—Vomiting—Furosemide—hypertension	5.51e-06	4.09e-05	CcSEcCtD
Bortezomib—Rash—Furosemide—hypertension	5.47e-06	4.06e-05	CcSEcCtD
Bortezomib—Dermatitis—Furosemide—hypertension	5.46e-06	4.05e-05	CcSEcCtD
Bortezomib—Vomiting—Betaxolol—hypertension	5.46e-06	4.05e-05	CcSEcCtD
Bortezomib—Nausea—Captopril—hypertension	5.46e-06	4.05e-05	CcSEcCtD
Bortezomib—Headache—Furosemide—hypertension	5.43e-06	4.03e-05	CcSEcCtD
Bortezomib—Rash—Betaxolol—hypertension	5.41e-06	4.02e-05	CcSEcCtD
Bortezomib—Dermatitis—Betaxolol—hypertension	5.41e-06	4.01e-05	CcSEcCtD
Bortezomib—Headache—Betaxolol—hypertension	5.38e-06	3.99e-05	CcSEcCtD
Bortezomib—Feeling abnormal—Lisinopril—hypertension	5.36e-06	3.98e-05	CcSEcCtD
Bortezomib—Gastrointestinal pain—Lisinopril—hypertension	5.32e-06	3.95e-05	CcSEcCtD
Bortezomib—Vomiting—Losartan—hypertension	5.32e-06	3.95e-05	CcSEcCtD
Bortezomib—Nausea—Perindopril—hypertension	5.3e-06	3.93e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Ramipril—hypertension	5.28e-06	3.92e-05	CcSEcCtD
Bortezomib—Nausea—Irbesartan—hypertension	5.28e-06	3.92e-05	CcSEcCtD
Bortezomib—Rash—Losartan—hypertension	5.27e-06	3.92e-05	CcSEcCtD
Bortezomib—Dermatitis—Losartan—hypertension	5.27e-06	3.91e-05	CcSEcCtD
Bortezomib—Headache—Losartan—hypertension	5.24e-06	3.89e-05	CcSEcCtD
Bortezomib—Nausea—Hydrochlorothiazide—hypertension	5.24e-06	3.89e-05	CcSEcCtD
Bortezomib—Urticaria—Lisinopril—hypertension	5.17e-06	3.84e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Timolol—hypertension	5.17e-06	3.84e-05	CcSEcCtD
Bortezomib—Nausea—Furosemide—hypertension	5.15e-06	3.82e-05	CcSEcCtD
Bortezomib—Asthenia—Ramipril—hypertension	5.15e-06	3.82e-05	CcSEcCtD
Bortezomib—Abdominal pain—Lisinopril—hypertension	5.14e-06	3.82e-05	CcSEcCtD
Bortezomib—Body temperature increased—Lisinopril—hypertension	5.14e-06	3.82e-05	CcSEcCtD
Bortezomib—Nausea—Betaxolol—hypertension	5.1e-06	3.79e-05	CcSEcCtD
Bortezomib—Pruritus—Ramipril—hypertension	5.07e-06	3.77e-05	CcSEcCtD
Bortezomib—Asthenia—Timolol—hypertension	5.03e-06	3.74e-05	CcSEcCtD
Bortezomib—Nausea—Losartan—hypertension	4.97e-06	3.69e-05	CcSEcCtD
Bortezomib—Pruritus—Timolol—hypertension	4.96e-06	3.68e-05	CcSEcCtD
Bortezomib—Diarrhoea—Ramipril—hypertension	4.91e-06	3.64e-05	CcSEcCtD
Bortezomib—Diarrhoea—Timolol—hypertension	4.8e-06	3.56e-05	CcSEcCtD
Bortezomib—Hypersensitivity—Lisinopril—hypertension	4.79e-06	3.56e-05	CcSEcCtD
Bortezomib—Dizziness—Ramipril—hypertension	4.74e-06	3.52e-05	CcSEcCtD
Bortezomib—Asthenia—Lisinopril—hypertension	4.67e-06	3.47e-05	CcSEcCtD
Bortezomib—Dizziness—Timolol—hypertension	4.64e-06	3.44e-05	CcSEcCtD
Bortezomib—Pruritus—Lisinopril—hypertension	4.6e-06	3.42e-05	CcSEcCtD
Bortezomib—Vomiting—Ramipril—hypertension	4.56e-06	3.39e-05	CcSEcCtD
Bortezomib—Rash—Ramipril—hypertension	4.52e-06	3.36e-05	CcSEcCtD
Bortezomib—Dermatitis—Ramipril—hypertension	4.52e-06	3.35e-05	CcSEcCtD
Bortezomib—Headache—Ramipril—hypertension	4.49e-06	3.34e-05	CcSEcCtD
Bortezomib—Vomiting—Timolol—hypertension	4.46e-06	3.31e-05	CcSEcCtD
Bortezomib—Diarrhoea—Lisinopril—hypertension	4.45e-06	3.3e-05	CcSEcCtD
Bortezomib—Rash—Timolol—hypertension	4.42e-06	3.28e-05	CcSEcCtD
Bortezomib—Dermatitis—Timolol—hypertension	4.42e-06	3.28e-05	CcSEcCtD
Bortezomib—Headache—Timolol—hypertension	4.39e-06	3.26e-05	CcSEcCtD
Bortezomib—Dizziness—Lisinopril—hypertension	4.3e-06	3.19e-05	CcSEcCtD
Bortezomib—Nausea—Ramipril—hypertension	4.26e-06	3.16e-05	CcSEcCtD
Bortezomib—Nausea—Timolol—hypertension	4.17e-06	3.09e-05	CcSEcCtD
Bortezomib—Vomiting—Lisinopril—hypertension	4.14e-06	3.07e-05	CcSEcCtD
Bortezomib—Rash—Lisinopril—hypertension	4.1e-06	3.05e-05	CcSEcCtD
Bortezomib—Dermatitis—Lisinopril—hypertension	4.1e-06	3.04e-05	CcSEcCtD
Bortezomib—Headache—Lisinopril—hypertension	4.08e-06	3.03e-05	CcSEcCtD
Bortezomib—Nausea—Lisinopril—hypertension	3.86e-06	2.87e-05	CcSEcCtD
Bortezomib—CYP2C8—Metabolism—GPX1—hypertension	6.41e-07	7.14e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP19A1—hypertension	6.41e-07	7.14e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—STK11—hypertension	6.41e-07	7.14e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADRA2A—hypertension	6.4e-07	7.13e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—hypertension	6.39e-07	7.12e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3R1—hypertension	6.39e-07	7.12e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PRKCA—hypertension	6.35e-07	7.07e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP1A1—hypertension	6.35e-07	7.07e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARA—hypertension	6.33e-07	7.06e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAT—hypertension	6.33e-07	7.05e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hypertension	6.29e-07	7.01e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GNAS—hypertension	6.28e-07	6.99e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CD36—hypertension	6.25e-07	6.96e-06	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AKT1—hypertension	6.2e-07	6.91e-06	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AKT1—hypertension	6.17e-07	6.87e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOB—hypertension	6.15e-07	6.85e-06	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AKT1—hypertension	6.14e-07	6.84e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AGT—hypertension	6.14e-07	6.83e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CALM1—hypertension	6.03e-07	6.72e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	6.02e-07	6.7e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—COMT—hypertension	6.01e-07	6.7e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOE—hypertension	6.01e-07	6.7e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—TH—hypertension	5.99e-07	6.67e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTM1—hypertension	5.98e-07	6.66e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CALM2—hypertension	5.97e-07	6.65e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—COMT—hypertension	5.96e-07	6.64e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAV1—hypertension	5.96e-07	6.63e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOA1—hypertension	5.94e-07	6.62e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALDH2—hypertension	5.93e-07	6.61e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARGC1A—hypertension	5.93e-07	6.6e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GNB3—hypertension	5.93e-07	6.6e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MTHFR—hypertension	5.92e-07	6.59e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HMOX1—hypertension	5.9e-07	6.57e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	5.9e-07	6.57e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARGC1A—hypertension	5.88e-07	6.55e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GNB3—hypertension	5.88e-07	6.55e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LPL—hypertension	5.87e-07	6.54e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HMOX1—hypertension	5.85e-07	6.52e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—hypertension	5.85e-07	6.51e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GCG—hypertension	5.83e-07	6.49e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC2A4—hypertension	5.83e-07	6.49e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAT—hypertension	5.82e-07	6.49e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARA—hypertension	5.81e-07	6.47e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HBA1—hypertension	5.78e-07	6.44e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAT—hypertension	5.77e-07	6.43e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GNAS—hypertension	5.77e-07	6.43e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP11A1—hypertension	5.75e-07	6.4e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ADCY5—hypertension	5.75e-07	6.4e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	5.74e-07	6.39e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GPX1—hypertension	5.73e-07	6.38e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GNAS—hypertension	5.72e-07	6.37e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PRKCA—hypertension	5.67e-07	6.31e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP1A1—hypertension	5.67e-07	6.31e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOB—hypertension	5.65e-07	6.3e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC9A1—hypertension	5.64e-07	6.29e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTT1—hypertension	5.64e-07	6.29e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT1—hypertension	5.64e-07	6.29e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AGT—hypertension	5.62e-07	6.26e-06	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AKT1—hypertension	5.62e-07	6.26e-06	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AKT1—hypertension	5.62e-07	6.26e-06	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AKT1—hypertension	5.62e-07	6.26e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOB—hypertension	5.6e-07	6.24e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCLC—hypertension	5.58e-07	6.21e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CETP—hypertension	5.58e-07	6.21e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CD36—hypertension	5.58e-07	6.21e-06	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TP53—hypertension	5.57e-07	6.2e-06	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TP53—hypertension	5.57e-07	6.2e-06	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TP53—hypertension	5.57e-07	6.2e-06	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AKT1—hypertension	5.54e-07	6.17e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CALM1—hypertension	5.53e-07	6.16e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOE—hypertension	5.51e-07	6.14e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTM1—hypertension	5.5e-07	6.12e-06	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TP53—hypertension	5.49e-07	6.11e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—STK11—hypertension	5.48e-07	6.1e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP19A1—hypertension	5.48e-07	6.1e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAV1—hypertension	5.46e-07	6.08e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTM1—hypertension	5.45e-07	6.07e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOA1—hypertension	5.45e-07	6.07e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LPL—hypertension	5.4e-07	6.01e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LPL—hypertension	5.35e-07	5.96e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP17A1—hypertension	5.34e-07	5.95e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ENO1—hypertension	5.29e-07	5.89e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS1—hypertension	5.29e-07	5.89e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ADCY5—hypertension	5.28e-07	5.89e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MTHFR—hypertension	5.28e-07	5.89e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GPX1—hypertension	5.27e-07	5.87e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ADCY5—hypertension	5.24e-07	5.83e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARG—hypertension	5.24e-07	5.83e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GPX1—hypertension	5.22e-07	5.81e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PRKCA—hypertension	5.21e-07	5.81e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP1A1—hypertension	5.21e-07	5.81e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARA—hypertension	5.18e-07	5.77e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PRKCA—hypertension	5.17e-07	5.76e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP1A1—hypertension	5.17e-07	5.76e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—hypertension	5.16e-07	5.75e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	5.14e-07	5.73e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—INS—hypertension	5.14e-07	5.72e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CD36—hypertension	5.13e-07	5.71e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTEN—hypertension	5.1e-07	5.68e-06	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—hypertension	5.09e-07	5.67e-06	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—hypertension	5.09e-07	5.67e-06	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—hypertension	5.09e-07	5.67e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—COMT—hypertension	5.09e-07	5.67e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CTGF—hypertension	5.09e-07	5.67e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CD36—hypertension	5.08e-07	5.66e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HMGCR—hypertension	5.05e-07	5.62e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT2—hypertension	5.05e-07	5.62e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GNB3—hypertension	5.02e-07	5.59e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARGC1A—hypertension	5.02e-07	5.59e-06	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—hypertension	5.02e-07	5.59e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AGT—hypertension	5.02e-07	5.59e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HMOX1—hypertension	5e-07	5.57e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADRA2A—hypertension	4.94e-07	5.5e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CALM1—hypertension	4.94e-07	5.5e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAT—hypertension	4.93e-07	5.49e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOE—hypertension	4.92e-07	5.48e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	4.9e-07	5.46e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GNAS—hypertension	4.89e-07	5.45e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAV1—hypertension	4.87e-07	5.43e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOA1—hypertension	4.86e-07	5.42e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—EP300—hypertension	4.86e-07	5.42e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MTHFR—hypertension	4.86e-07	5.41e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MTHFR—hypertension	4.82e-07	5.37e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARG—hypertension	4.8e-07	5.35e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOB—hypertension	4.79e-07	5.33e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARA—hypertension	4.77e-07	5.31e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—hypertension	4.73e-07	5.27e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARA—hypertension	4.73e-07	5.26e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—INS—hypertension	4.71e-07	5.24e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—hypertension	4.71e-07	5.24e-06	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AKT1—hypertension	4.7e-07	5.23e-06	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AKT1—hypertension	4.7e-07	5.23e-06	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AKT1—hypertension	4.7e-07	5.23e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTM1—hypertension	4.66e-07	5.19e-06	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AKT1—hypertension	4.63e-07	5.16e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—TH—hypertension	4.62e-07	5.15e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AGT—hypertension	4.62e-07	5.14e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CALM2—hypertension	4.61e-07	5.13e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AGT—hypertension	4.58e-07	5.1e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LPL—hypertension	4.57e-07	5.09e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CALM1—hypertension	4.54e-07	5.06e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOE—hypertension	4.52e-07	5.04e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3R1—hypertension	4.5e-07	5.02e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—hypertension	4.5e-07	5.02e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CALM1—hypertension	4.5e-07	5.01e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC2A4—hypertension	4.5e-07	5.01e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCG—hypertension	4.5e-07	5.01e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOE—hypertension	4.49e-07	5e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAV1—hypertension	4.48e-07	4.99e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADCY5—hypertension	4.48e-07	4.99e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOA1—hypertension	4.47e-07	4.98e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GPX1—hypertension	4.46e-07	4.97e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAV1—hypertension	4.44e-07	4.95e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOA1—hypertension	4.43e-07	4.94e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PRKCA—hypertension	4.42e-07	4.92e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP1A1—hypertension	4.42e-07	4.92e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT1—hypertension	4.36e-07	4.85e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CD36—hypertension	4.34e-07	4.84e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—hypertension	4.32e-07	4.81e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARG—hypertension	4.28e-07	4.77e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—STK11—hypertension	4.23e-07	4.71e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP19A1—hypertension	4.23e-07	4.71e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—hypertension	4.23e-07	4.71e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—INS—hypertension	4.2e-07	4.68e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3R1—hypertension	4.13e-07	4.6e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—hypertension	4.13e-07	4.6e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—hypertension	4.12e-07	4.59e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MTHFR—hypertension	4.12e-07	4.59e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARA—hypertension	4.04e-07	4.5e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARG—hypertension	3.94e-07	4.39e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—COMT—hypertension	3.93e-07	4.38e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AGT—hypertension	3.91e-07	4.36e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARG—hypertension	3.91e-07	4.35e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—hypertension	3.89e-07	4.33e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GNB3—hypertension	3.88e-07	4.32e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARGC1A—hypertension	3.88e-07	4.32e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—INS—hypertension	3.87e-07	4.3e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HMOX1—hypertension	3.86e-07	4.3e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—hypertension	3.85e-07	4.29e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—hypertension	3.85e-07	4.29e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CALM1—hypertension	3.85e-07	4.28e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOE—hypertension	3.83e-07	4.27e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—INS—hypertension	3.83e-07	4.27e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAT—hypertension	3.81e-07	4.24e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAV1—hypertension	3.8e-07	4.23e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOA1—hypertension	3.79e-07	4.22e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—hypertension	3.78e-07	4.21e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GNAS—hypertension	3.77e-07	4.2e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOB—hypertension	3.7e-07	4.12e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3R1—hypertension	3.69e-07	4.1e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—hypertension	3.69e-07	4.1e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTM1—hypertension	3.6e-07	4e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTEN—hypertension	3.59e-07	4e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—hypertension	3.54e-07	3.95e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LPL—hypertension	3.53e-07	3.93e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—hypertension	3.51e-07	3.91e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADCY5—hypertension	3.45e-07	3.85e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GPX1—hypertension	3.44e-07	3.83e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—EP300—hypertension	3.43e-07	3.82e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRKCA—hypertension	3.41e-07	3.8e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP1A1—hypertension	3.41e-07	3.8e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3R1—hypertension	3.39e-07	3.78e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—hypertension	3.39e-07	3.78e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—hypertension	3.37e-07	3.75e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—hypertension	3.36e-07	3.74e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3R1—hypertension	3.36e-07	3.74e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CD36—hypertension	3.35e-07	3.73e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARG—hypertension	3.34e-07	3.72e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTEN—hypertension	3.29e-07	3.67e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—hypertension	3.29e-07	3.67e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—INS—hypertension	3.27e-07	3.65e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MTHFR—hypertension	3.18e-07	3.54e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—EP300—hypertension	3.14e-07	3.5e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARA—hypertension	3.12e-07	3.47e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—hypertension	3.1e-07	3.45e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—hypertension	3.07e-07	3.42e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AGT—hypertension	3.02e-07	3.36e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—hypertension	3e-07	3.34e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CALM1—hypertension	2.97e-07	3.31e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOE—hypertension	2.96e-07	3.29e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTEN—hypertension	2.94e-07	3.27e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AKT1—hypertension	2.94e-07	3.27e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAV1—hypertension	2.93e-07	3.26e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOA1—hypertension	2.92e-07	3.26e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—hypertension	2.87e-07	3.2e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3R1—hypertension	2.87e-07	3.2e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—EP300—hypertension	2.8e-07	3.12e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTEN—hypertension	2.7e-07	3.01e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTEN—hypertension	2.68e-07	2.99e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—hypertension	2.63e-07	2.93e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—EP300—hypertension	2.58e-07	2.87e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARG—hypertension	2.58e-07	2.87e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—EP300—hypertension	2.56e-07	2.85e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—hypertension	2.54e-07	2.83e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—INS—hypertension	2.53e-07	2.81e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—hypertension	2.32e-07	2.58e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTEN—hypertension	2.29e-07	2.55e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—hypertension	2.22e-07	2.47e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3R1—hypertension	2.22e-07	2.47e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—EP300—hypertension	2.18e-07	2.43e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AKT1—hypertension	2.07e-07	2.31e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—hypertension	2.03e-07	2.26e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AKT1—hypertension	1.9e-07	2.11e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTEN—hypertension	1.77e-07	1.97e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AKT1—hypertension	1.69e-07	1.89e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—EP300—hypertension	1.69e-07	1.88e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AKT1—hypertension	1.56e-07	1.74e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AKT1—hypertension	1.54e-07	1.72e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AKT1—hypertension	1.32e-07	1.47e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AKT1—hypertension	1.02e-07	1.13e-06	CbGpPWpGaD
